Hemichannel-mediated release of lactate by Karagiannis, Anastassios et al.
                          Karagiannis, A., Sylantyev, S., Hadjihambi, A., Hosford, P. S., Kasparov, S.,
& Gourine, A. V. (2016). Hemichannel-mediated release of lactate. Journal
of Cerebral Blood Flow and Metabolism, 36(7), 1202-1211. DOI:
10.1177/0271678X15611912
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1177/0271678X15611912
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Sage at
https://doi.org/10.1177/0271678X15611912 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Original Article
Hemichannel-mediated release of lactate
Anastassios Karagiannis1, Sergiy Sylantyev2, Anna Hadjihambi1,
Patrick S Hosford1, Sergey Kasparov3
and Alexander V Gourine1
Abstract
In the central nervous system lactate contributes to the extracellular pool of readily available energy substrates and may
also function as a signaling molecule which mediates communication between glial cells and neurons. Monocarboxylate
transporters are believed to provide the main pathway for lactate transport across the membranes. Here we tested the
hypothesis that lactate could also be released via opening of pannexin and/or functional connexin hemichannels. In acute
slices prepared from the brainstem, hippocampus, hypothalamus and cortex of adult rats, enzymatic amperometric
biosensors detected significant tonic lactate release inhibited by compounds, which block pannexin/connexin hemichan-
nels and facilitated by lowering extracellular [Ca2þ] or increased PCO2. Enhanced lactate release triggered by hypoxia
was reduced by 50% by either connexin or monocarboxylate transporter blockers. Stimulation of Schaffer collateral
fibers triggered lactate release in CA1 area of the hippocampus, which was facilitated in conditions of low extracellular
[Ca2þ], markedly reduced by blockade of connexin hemichannels and abolished by lactate dehydrogenase inhibitor
oxamate. These results indicate that lactate transport across the membranes may occur via mechanisms other than
monocarboxylate transporters. In the central nervous system, hemichannels may function as a conduit of lactate release,
and this mechanism is recruited during hypoxia and periods of enhanced neuronal activity.
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Introduction
Neurons require constant and suﬃcient supply of
energy substrates to meet their metabolic needs.
Lactate is one of the key elements of brain energy
metabolism and contributes to the extracellular pool
of readily available energy substrates. The so-called
‘astrocyte-to-neuron lactate shuttle’ hypothesis suggests
that neuronal activity is fuelled by lactate provided by
neighbouring astrocytes.1,2 Although there is evidence
which argues against the importance (and existence) of
astrocyte-to-neuron lactate shuttle (for a comprehen-
sive review see Dienel3), the role of lactate and its eﬀect-
ive transport in supporting metabolic needs of the brain
may become highly signiﬁcant in certain conditions.
For example, physical activity and exercise are asso-
ciated with progressive increase in brain lactate
uptake (from the blood) and oxidation as work load
and plasma lactate levels rise.4,5 In addition to its meta-
bolic role, lactate may also function as a signaling
molecule which in the brain mediates communication
between astrocytes and neurons.6–9
In order to fulﬁl metabolic (at rest or during exer-
cise) and/or signaling roles, lactate requires an eﬀective
mechanism of transport across the membrane(s) – the
process which is currently attributed to the operation
of monocarboxylate transporters (MCTs).10 This,
however, does not exclude the involvement of other
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potential mechanisms.11 Gap junction hemichannels
have been reported to be permeable to various molecules
including adenosine 5’-triphosphate (ATP), glutamate
and glucose,12–18 and in this study we tested the hypoth-
esis that lactate could be released into the extracellular
space via opening of pannexin and/or functional (i.e.
unopposed) gap junction connexin hemichannels.
Materials and methods
All the experiments were performed in accordance
with the European Commission Directive 2010/63/
EU (European Convention for the Protection of
Vertebrate Animals used for Experimental and Other
Scientiﬁc Purposes) and the UK Home Oﬃce (Scientiﬁc
Procedures) Act (1986) with project approval from the
UCL Institutional Animal Care and Use Committee.
In vitro slice preparations
Young adult Sprague-Dawley rats (120 g) were ter-
minally anesthetized with halothane inhalation over-
dose, the brains were removed and placed in ice cold
artiﬁcial cerebrospinal ﬂuid (aCSF) containing 124mM
NaCl, 26mM NaHCO3, 3mM KCl, 2mM CaCl2,
1.25mM NaH2PO4, 1mM MgSO4, 10mM Glucose
saturated with 95% O2/5% CO2 (pH 7.4) with an add-
ition of 9mM Mg2þ. Horizontal brainstem slices con-
taining the intact ventral surface (thickness 400 mm)
or coronal brainstem, hypothalamic or cortical slices
(thickness 300 mm) were cut using a vibratome and
then incubated at room temperature for 1 h in a stand-
ard aCSF saturated with 95% O2/5% CO2.
Biosensor recordings
Release of lactate was recoded in real-time using
amperometric enzymatic lactate biosensors (Sarissa
Biomedical) placed in a direct contact with the surface
of the slice. The operation of the lactate biosensor is
based on enzymatic activity of lactate oxidase which, in
the presence of oxygen, converts lactate to pyruvate
and H2O2. The latter is detected electrochemically.
Figure 1 illustrates linearity of lactate detection by the
biosensors in concentrations from 10 mM to 500 mM
and insensitivity of the lactate biosensor detection
system to pharmacological agents used in the current
study. A dual recording conﬁguration of a null sensor
(lacking lactate oxidase) and lactate biosensor was used
(Figure 2(a)), as described previously.19–22 The null
sensor served as a control to determine whether any
non-speciﬁc electroactive interferents were released
Figure 1. Performance of the lactate biosensors. (a) Current (I) calibration curve and sample responses of the lactate biosensor
demonstrating linearity of analyte detection in concentrations from 10 mM to 500 mM; (b) Insensitivity of the lactate biosensor
detection system to pharmacological agents used in this study. Traces illustrate sample biosensor current responses to lactate
(100 mM) when calibrated in control artificial cerebrospinal fluid (aCSF), and then in the presence of (i) carbenoxolone (CBX),
(ii) 5-nitro-2 -(3-phenylpropylamino)-benzoic acid (NPPB, 200 mM), (iii) probenecid (Prob, 150 mM), (iv) a-cyano-4-hydroxycinnamate
(4-CIN, 250mM), (v) Ruthenium red (RuR, 20mM), and (vi) tetrodotoxin (TTX, 1 mM) þ muscimol (100 mM).
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Figure 2. Hemichannel-mediated tonic release of lactate. (a) Schematic illustration of a dual recording configuration of lactate and null
(control) biosensors placed in a direct contact with the surface of the coronal cortical slice or uncut ventral surface of the horizontal
brainstem slice. Difference in current between lactate and null biosensors was used to determine the amount of lactate release.
XII hypoglossal rootlets; (b) Representative example of oxamate-induced changes in lactate release detected by the biosensors placed on the
surface of the brainstem slice followed by calibration with 100mM lactate; (c) Representative example of changes in lactate biosensor current
during calibration by application of 100mM lactate, after biosensor placement in a direct contact with the surface of the brainstem slice
(revealing lactate tone), and in response to lowering extracellular [Ca2þ] (indicated by grey shading); (d) Representative recordings of lactate
biosensor current showing changes in lactate tone in response to application of CBX (100mM), NPPB (200mM), 4-CIN (250mM), or co-
application of TTX (1mM) and muscimol (100mM). Period of drug application is indicated by grey shading; (e) Summary data illustrating peak
changes in tonic lactate release in response to lowering extracellular [Ca2þ] (in the absence and presence of CBX, 100mM), increases in
PCO2, or application of compounds known to inhibit functional connexin hemichannels (CBX, 100mM; NPPB, 200mM; La
3þ, 100mM),
pannexin hemichannels (CBX, 10mM; Prob, 150mM), monocarboxylate transporters (4-CIN, 250mM), CALHM1 channels (RuR, 20mM) or
suppress the neuronal activity (TTX, 1mM þ muscimol, 100mM). Mean  SEM. p values – Wilcoxon signed-rank test.
Hip: hippocampus; py: pyramidal tract.
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and confound the measurements. Null sensor currents
were subtracted from the lactate biosensor currents.
Biosensors were calibrated with known amount of lac-
tate (10 or 100mM) directly in the slice chamber (i.e. in
the identical temperature, aCSF composition/osmolar-
ity conditions) immediately before and after the record-
ings (Figure 2(b) and (c)). To convert changes in sensor
current to changes in lactate concentration, the means
of the initial and ﬁnal calibrations were used.
Recordings were made from the slice placed on an
elevated grid in a ﬂow chamber at 35C. Isohydric hyper-
capnia was mimicked by replacing normal aCSF with a
solution containing 70mM NaCl, 80mM NaHCO3,
3mM KCl, 2mM CaCl2, 1.25mM NaH2PO4, 1mM
MgSO4, 10mM Glucose saturated with 12% CO2
(PCO2 70–80mmHg, pH 7.4). Hypoxic conditions were
induced for 2–4min by replacement of oxygen in the
medium with nitrogen (perfusion of the chamber with
aCSF saturated with 95% N2/5% CO2). The eﬀect of
hypoxia was determined by measuring the peak lactate
release upon re-oxygenation (Figure 3(a)) as previously
described.22 This represents an accurate estimation of
peak hypoxia-induced lactate release since similar release
is triggered by application of a mitochondrial complex III
inhibitor myxothiazol (2.5mM) (Figure 3(b) and (c)).
Electrophysiology
Coronal hippocampal slices (250 mm) were cut from the
brains of 25–30-day-old Sprague-Dawley rats and incu-
bated for 1 h in normal aCSF saturated with 95%
O2/5% CO2 (pH 7.4). Recordings were made in aCSF
containing 2mM CaCl2 and 2mM MgCl2 at 33–35
C.
AMPA-receptor (AMPAR)-mediated currents were
isolated by adding CGP-55845 (1mM), D-APV
(50 mM), strychnine (1 mM), picrotoxin (100 mM) and
S-MCPG (200mM). The pipette solution contained
117.5mM Cs-gluconate, 17.5mM CsCl, 10mM KOH-
HEPES, 10mM BAPTA, 8mM NaCl, 5mM QX-314,
2mM Mg-ATP, 0.3mM GTP (pH 7.2, 295 mOsm,
resistance 7–9MV). Damaged cells from the slice sur-
face were removed by applying ﬂow of pressurized
Figure 3. Facilitated release of lactate in response to hypoxia. (a) Representative example of changes in lactate biosensor current
during calibration, after biosensor placement on the surface of the brainstem slice, and in response to a hypoxic challenge (perfusion
with aCSF saturated with 95% N2/5% CO2). Peak hypoxia-induced lactate release is measured upon re-oxygenation. (b)
Representative examples of changes in lactate biosensor current recorded during and after hypoxia when the sensor is placed on the
surface of the brain slice (left) or in the bath away from the slice (right) and on the surface of the slice during application of myxothiazol
(middle). Decrease in O2 availability reduces biosensor current followed by a positive signal upon re-oxygenation (hypoxia-induced
lactate release), which is only observed when the sensor is in a direct contact with the brain tissue. (c) Peak lactate efflux of a similar
magnitude is triggered by hypoxia and myxothiazol.
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perfusion solution delivered via a glass pipette (diam-
eter 7–10 mm). Whole-cell voltage-clamp recordings
were taken from CA1 pyramidal neurons. Signals
were digitized at 10 kHz. Stimulation was applied
using a bipolar tungsten electrode placed in the
Schaﬀer collaterals area. Electrical stimuli were deliv-
ered every 15 s for 10min in each experimental episode
(application of drugs, change of extracellular [Ca2þ]);
10min intervals without stimulation were given
between experimental episodes. Miniature (20 mm tip
diameter) carbon ﬁber lactate biosensors were placed in
the vicinity (within 15–20 mm) of the recorded neurons.
Readings of the biosensor currents were taken every
0.5 s, and were synchronized with the recordings of
the whole-cell AMPAR-mediated EPSCs.
Drugs
Carbenoxolone (CBX) in 10 mM concentration and
probenecid (150mM) were used to inhibit pannexin
hemichannel activity. CBX (100-200 mM), 5-nitro-2 -
(3-phenylpropylamino)-benzoic acid (NPPB) (200mM)
and La3þ (100mM) were used to interfere with connexin
hemichannels. MCTs were inhibited with 4-CIN (250–
500 mM). Ruthenium red (20mM) was used to block
CALHM1 channels. Tetrodotoxin (1 mM) and musci-
mol (100 mM) were applied to inhibit neuronal activity.
EGTA (1mM) was used to chelate Ca2þ. All drugs
were from Sigma (Poole, UK).
Data analysis
Lactate biosensor measurements were processed using
1401 interface and analyzed using Spike 2 software
(Cambridge Electronic Design). Data are reported as
meanS.E.M. Datasets were compared using paired
samples Wilcoxon Signed Ranks Test or Student’s
paired or unpaired t test, as appropriate. Diﬀerences
between groups with p values of less than 0.05 were
considered signiﬁcant.
Results
Enzymatic amperometric lactate biosensors were used
for real-time recordings of tonic-, hypoxia- and
enhanced neuronal activity-stimulated release of lactate
in acute slices of rat brainstem, hypothalamus, hippo-
campus and cortex.
Hemichannel-mediated tonic release of lactate
Tonic lactate eﬄux (lactate tone; Figure 2(c)) was
detected when lactate biosensors were placed in a
direct contact with the uncut ventral surface of the
brainstem horizontal slices (278 12 mM; n¼ 100,
p< 0.001), coronal hypothalamic slices (349 46 mM;
n¼ 8, p¼ 0.007), or coronal cortical slices
(229 15 mM; n¼ 10, p¼ 0.003). Lactate tone detected
on the slice surface was dramatically reduced by appli-
cation of lactate dehydrogenase inhibitor oxamate
(20mM) (reduction in tone by 76 7%, n¼ 19,
p< 0.001, Figure 2(b)), conﬁrming the analyte selectiv-
ity of the biosensor detection system.
Opening probability of hemichannels increases when
extracellular [Ca2þ] decreases.23 Lowering extracellular
[Ca2þ] (from 2mM to 0mM with an addition of 1mM
EGTA to chelate residual Ca2þ) facilitated release of
lactate by the brainstem (by 94 15 mM; n¼ 22,
p¼ 0.001) and cortical (by 109 15 mM; n¼ 5,
p¼ 0.03) slices (Figure 2(c) and (e)). Opening probabil-
ity of certain connexin hemichannels (e.g. connexin26)
also increases in response to CO2.
15,24,25 Isohydric
hypercapnia (application of aCSF containing 80mM
HCO3
, PCO2 70-80mmHg, pH 7.4) facilitated lactate
release from the ventral surface of the brainstem (by
37 7 mM; n¼ 10, p¼ 0.003, Figure 2(e)). These data
suggested that hemichannels may act as a conduit for
lactate release.
To further investigate the role of pannexin/connexin
hemichannels in mediating tonic release of lactate,
we next applied compounds known to inhibit hemi-
channel activity. CBX and NPPB which block both
pannexin and connexin hemichannels signiﬁcantly
reduced lactate tone (Figure 2(d) and (e)). CBX
(100mM) decreased lactate tone by 65 12 mM
(n¼ 14, p< 0.001) in the brainstem slices and by
71 7 mM (n¼ 5, p¼ 0.03) in the cortical slices. NPPB
(200mM) had a similar eﬀect in the brainstem slices
(decrease in lactate tone by 108 17 mM (35%); n¼ 8,
p¼ 0.007). The amount of lactate released in response
to lowering extracellular [Ca2þ] was also markedly
reduced in the presence of CBX (64 22%, n¼ 8,
p¼ 0.02; Figure 2(e)).
Lactate tone was not aﬀected by La3þ (100mM,
Figure 2(e)) which is believed to inhibit connexin, but
not pannexin hemichannels,26,27 suggesting that the
latter might be involved. Indeed, inhibition of pannex-
ins by application of CBX at a low concentration
(10 mM) or probenecid (150 mM) decreased lactate
tone (CBX 10 mM: 29 9 mM, n¼ 12, p¼ 0.002; pro-
benecid: 31 9 mM, n¼ 13, p¼ 0.003) (Figure 2(e)).
Interestingly, inhibitor of MCTs 4-CIN (250-500mM)
had no eﬀect on tonic release of lactate by either brain-
stem or cortical slices (Figure 2(d) and (e)). Inhibition
of neuronal activity by co-application of tetrodotoxin
(TTX, 1 mM) and muscimol (100 mM) was associated
with a small reduction in lactate tone (12 4 mM;
n¼ 9, p¼ 0.01, Figure 2(d) and (e)). Application of
ruthenium red (20mM) to block CALHM1 channels
(which are also sensitive to low extracellular [Ca2þ]28)
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did not reduce the lactate tone (increase by
4.4 1.6 mM, n¼ 10, Figure 2(e)).
Control tests were performed to determine whether the
pharmacological agents used in this study have an eﬀect
on lactate biosensor detection system (Figure 1(b)). Only
NPPB (200mM) was found to reduce biosensor current
by 10%, which is signiﬁcantly less compared to the
eﬀect of the drug on currents generated by the biosensors
when positioned on the brain slice (reduction in lactate
tone by 35% and reduction in hypoxia-induced lactate
release by >50%, see below).
Connexin hemichannels and MCTs mediate
facilitated release of lactate during hypoxia
Tissue hypoxia decreases mitochondrial utilization of
pyruvate leading to an increase in lactate production
and release. Since biosensors require oxygen to operate
(lactate oxidase entrapped in the biosensor polymer
layer converts lactate to pyruvate and H2O2 which is
detected electrochemically), decreases in O2 concentra-
tion (saturation of the media with 95%N2/5%CO2)
reduce biosensor currents (Figure 3(a) and (b)).
Therefore, lactate release induced by hypoxia can
only be determined upon re-oxygenation22 (increase in
lactate release in the brainstem slices from 219 16 mM
to 284 18 mM; n¼ 61; p< 0.001; in the cortical slices
from 182 10 mM to 302 26 mM; n¼ 5; p¼ 0.03).
These values represent an accurate estimation of peak
hypoxia-induced lactate release since lactate eﬄux of a
similar magnitude is triggered by bath application of
the mitochondrial complex III inhibitor myxothiazol
(Figure 3(b) and (c)). Hypoxia-induced lactate release
was not aﬀected by CBX applied at a low concentration
(10 mM) (Figure 4(b)) or probenecid, suggesting that
pannexins are not involved. However, lactate release
triggered by hypoxia was signiﬁcantly (by 50%)
reduced in the presence of either MCTs inhibitor 4-
CIN (250mM, p¼ 0.03) or any of the tested connexin
hemichannel blockers (CBX 100 mM, p¼ 0.006; NPPB,
p¼ 0.007; or La3þ, p¼ 0.001) (Figure 4(a) and (b)).
Blockade of the neuronal activity with TTX and mus-
cimol resulted in a slightly higher peak lactate release in
response to hypoxic challenge (Figure 4(a) and (b)).
Connexin hemichannels contribute to the release
of lactate triggered by enhanced neuronal activity
We next examined hemichannel involvement in the
release of lactate driven by enhanced neuronal activ-
ity.29 Miniature (20 mm in diameter) carbon ﬁber
lactate biosensors placed in the vicinity of the patch-
clamped hippocampal CA1 neurons (Figure 5(a)) rec-
orded signiﬁcant (peak release 35 3 mM, n¼ 11) lac-
tate release in response to stimulation of Schaﬀer
collateral ﬁbers (Figure 5(b) and (d)). Lactate release
in CA1 in response to stimulation of Schaﬀer collaterals
was increased in low extracellular [Ca2þ] (0.2mM)
conditions (peak release 48 4 mM, n¼ 5, p< 0.05;
Figure 5(b) and (d)), abolished in the presence of
oxamate applied 20min prior (n¼ 5, p< 0.001; Figure
5(b) and (d)), and markedly reduced by CBX (peak
release 12 2 mM, n¼ 6; p< 0.001; Figure 5(d)).
Simultaneous recordings of AMPA-receptor-mediated
EPSCs showed that decreased release of lactate in the
presence of CBX is associated with small decreases in
the amplitude of the evoked EPSCs (Figure 5(c) and
(e)). CBX applied at a low concentration (10 mM) had
no eﬀect on the evoked EPSCs and activity-dependent
lactate release (Figure 5(c) to (e)).
Discussion
Lactate is continuously produced by the brain paren-
chyma even in conditions of ample oxygen supply.30
Glycolysis in the presence of oxygen (aerobic glycolysis)
is an interesting feature of brain metabolism, and in
resting conditions there is a net eﬄux of lactate from
the CNS, i.e. lactate concentration in the venous blood
is higher than in the arterial blood supplying the
brain.31,32 For decades it has been thought that
MCTs are the only pathway of lactate transport from
the cells which produce it. This dogma was challenged
by the results of the recent study suggesting that lactate
release may occur via the mechanisms involving certain
membrane channels.11 The data obtained in the present
study suggest that these alternative mechanisms include
pannexin and functional connexin hemichannels. We
report that hemichannels are capable to function as a
conduit of lactate release and this mechanism is
recruited during hypoxia and periods of enhanced neur-
onal activity.
We show that tonic eﬄux of lactate can indeed
be detected in hyperoxygenated environment
(PO2> 500mmHg in standard conditions used for the
experiments in brain slices superfused with aCSF satu-
rated with 95% O2/5% CO2) in reduced preparations,
such as acute brainstem, hypothalamic or cortical
slices. Lactate tone detected on the intact ventral brain-
stem surface was similar to that recorded by the bio-
sensors placed in a direct contact with coronal brain
sections, indicating that damaged cells are not the pri-
mary source of this release. Lactate tone increased in
conditions of low extracellular [Ca2þ] or high PCO2,
which favor hemichannel opening,15,24,25,33 and
decreased in the presence of pharmacological agents
known to inhibit pannexin and connexin hemichannels.
Eﬄux of lactate facilitated by hypoxia was signiﬁcantly
reduced by either connexin or MCT blockers. Lactate
release in CA1 triggered in response to stimulation of
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Schaﬀer collaterals was enhanced in low extracellular
[Ca2þ] and reduced by CBX. This is interesting because
lowering extracellular [Ca2þ] should reduce the synaptic
strength and aﬀect neuronal responses in the projection
area. This observation suggests that release of lactate
might be uncoupled from synaptic activity responding
to ionic movements associated with axonal and den-
dritic membrane potentials propagation. For example,
there is recent evidence showing that an increase in
extracellular concentration of Kþ (within the physio-
logical range) is suﬃcient to trigger release of lactate
by astrocytes.11 Through hemichannels or other
unidentiﬁed channels,11 the lactate anion (Lac) can
exit cells without the involvement of the proton and
facilitate Naþ entry (through the activity of sodium-
coupled MCTs), which is required by the Naþ/
KþATPase for uptake of neuronally released Kþ.
It needs to be acknowledged that none of the pharma-
cological compounds available today are speciﬁc hemi-
channel blockers. Nevertheless, they all have diﬀerent oﬀ
target eﬀects strongly suggesting that hemichannels are
responsible for this lactate release. Facilitated lactate
release in response to lowering extracellular [Ca2þ] or
increases in tissue PCO2 further supports this conclusion.
Figure 4. Connexin hemichannels and monocarboxylate transporters (MCTs) mediate facilitated release of lactate during hypoxia.
(a) Representative recordings of changes in lactate biosensor current showing hypoxia-induced lactate release by the brainstem slices
in the absence and presence of CBX (100 mM), NPPB (200mM), 4-CIN (250 mM) or co-application of TTX (1mM) and muscimol
(100 mM); (b) Summary data illustrating peak hypoxia-induced lactate release in the absence and presence of CBX, NPPB, La3þ, 4-CIN,
TTXþmuscimol.
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Our pharmacological survey also suggests that other mem-
brane channels sensitive to changes in extracellular [Ca2þ]
(e.g. CALHM1, eﬀectively blocked by Ruthenium red) are
unlikely to be involved.
These results provide strong evidence that MCTs are
not the sole conduit of lactate release in the CNS. It is
rather surprising that the evidence of membrane
channel-mediated lactate release was only recently
reported,11 considering that molecules as large as ATP
and glucose are known to be transported via hemichan-
nel opening.12–18,25 All cells of the brain parenchyma
(neurons, astrocytes, oligodendrocytes and microglia)
express pannexins and connexins and identiﬁcation of
the exact source(s) of lactate release detected by the
Figure 5. Connexin hemichannels contribute to the increases in lactate release triggered by enhanced neuronal activity. (a)
Schematic drawing of the experimental design. Miniature (20 mm) carbon fiber lactate biosensors were placed in the vicinity of the
patch-clamped hippocampal CA1 neurons to record lactate release in response to electrical stimulation of Schaffer collateral (SC)
fibers; (b) Representative recordings of changes in biosensor current illustrating lactate release in CA1 in response to stimulation of
Schaffer collaterals in control and low (0.2mM) extracellular [Ca2þ] conditions and in the presence of oxamate (20mM). Schaffer
collaterals were stimulated for 10min; (c) Representative AMPAR EPSCs recorded in the same experiment in the absence and
presence of CBX (each trace is an average of 10); (d) Summary data illustrating peak lactate release in CA1 area in response to
stimulation of Schaffer collaterals in control and low extracellular [Ca2þ] conditions, in the presence of oxamate or CBX; (e) Summary
data illustrating amplitudes of AMPAR-mediated EPSCs normalized to the control values.
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biosensors on the surface of the brain slice in vitro is
beyond the scope of the present study. Nevertheless,
the existing evidence points to astroglia as an important
source of lactate release. Recent studies involving meas-
urements of cytosolic lactate concentration in astrocytes
using genetically encoded ﬂuorescence sensors reported
values of 1.4mM and concluded that at resting condi-
tions astrocytes maintain a steady-state reservoir of lac-
tate allowing its rapid mobilization.11 Pharmacological
compounds which are expected to signiﬁcantly reduce
neuronal activity (TTX and muscimol) had only a
small eﬀect on tonic lactate release, while astroglial
activity appears to correlate well with lactate production
and release by these cells.2,6,11
In summary, we show that pannexin and/or connexin
hemichannels are capable of functioning as a conduit of
lactate transport across the membrane and this mechan-
ism is recruited in conditions of low PO2, high PCO2 or
during periods of enhanced neuronal activity. The identi-
ﬁed mechanism may play a role in providing rapid and
eﬀective local supply of lactate to meet increased meta-
bolic demands of active neurons. Indeed, extracellular
[Ca2þ] can decrease to0.7mM during periods of intense
neuronal activity.34–37 This would increase opening prob-
ability of hemichannels expressed by neighbouring astro-
cytes leading to highly localized neuronal activity-driven
release of lactate ‘‘on-site’’. Neuronal activity-dependent
opening of connexin hemichannels triggered by decreases
in extracellular [Ca2þ] (and leading to the release of ATP)
has been demonstrated previously.38 At rest, hemichan-
nel-mediated mechanisms may contribute to the convect-
ive ﬂux of lactate across the astrocytic syncytium and its
clearance from the brain via the circulation3 and/or the
glymphatic system.39 During physical activity, when per-
ipheral lactate is fuelling our brains, hemichannels are
hypothesized to play an important role in the eﬀective
uptake of this metabolic substrate from the arterial blood.
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